CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Roche turns to Dualitas to find new bispecific approaches for immunology

PartnershipPositive
AI Analysis

Summary

Roche has partnered with Dualitas to screen 300,000 new bispecific antibody combinations for inflammatory and immunology applications, with an upfront payment of $36.5 million.

Importance:7/10
Sentiment:
0.60
bispecific antibodiesimmunologyinflammatory conditionspartnershipdrug discovery
Related Companies

Read the original article

Published by Endpoints News on September 17, 2026 10:00 AM

Read Original